Irish firm creates jobs with tinnitus medical device

Neuromod Devices will create an additional 50 jobs for Dublin over the coming years.

The announcement came as Neuromod Devices launched Mutebutton a new device for the treatment of tinnitus.  The company is headquartered in NovaUCD, the Centre for New Ventures and Entrepreneurs at University College Dublin.

Neuromod Devices plan to achieve the creation of 50 new jobs over the next five years in Dublin. These roles will be key in supporting the company’s global growth targets to become a leading global provider of non-surgical neuromodulation treatments for chronic conditions.

This project has been supported by the Department of Jobs, Enterprise and Innovation through Enterprise Ireland.

Enterprise Ireland, IMDA and IDA Ireland announced Neuromod Devices as winner of The Emerging Medical Company of the Year 2014 – 2015 at the 8th annual Medical Industry Excellence Awards.

Mutebutton is a clinically-proven, self-administered treatment designed to alleviate the symptoms of chronic tinnitus sufferers. It is the culmination of over four years of research and development since the company was first founded in 2010 by CEO, Dr Ross O’Neill.

Minister Bruton said, "A key part of our Action Plan for Jobs is turning good ideas into good jobs. Over the past decade we have invested heavily in government-supported research and innovation – the challenge we have been trying to address in the past three years is to build on that to create commercial ideas and ultimately jobs. Today Neuromod is announcing that it is creating an extra 50 high-end jobs in Dublin as a result of a product it has created through innovation it has carried out – this is a great example of what we are trying to achieve.”